Special Issue "Medicines Optimisation"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (28 February 2015).
Interests: paediatric medicines use; barriers to novel medicines development (in paediatrics); predicting and evaluating medicines adherence; risk in pharmaceutical systems; optimisation of antibiotics use; toolkits to optimise prescribing
The use of medicines has been one of the most common therapeutic interventions for centuries. However, we are now conscious of the extended range and costs of medications available and the complexity involved with their use. Consequently, in order to gain the most from our use of medicines, and to maximise benefit to patients on an individual or public health scale, we need to routinely apply and further develop the concept of “medicines optimisation”. This will involve greater understanding of the medicines optimisation concept, through knowledge of patients’ healthcare needs, development of the evidence base for the use of medications and a universal drive to refine the safety of medicines use. These principles apply across the medicines use pathway, from the prescribing process, through medication supply systems to the involved activities associated with either the supervised or patient managed administration of drugs and the subsequent medicines review processes. The ultimate goal is to improve outcomes for patients.
If you are involved in developing any aspect of the medicines optimisation process or agenda then we would be keen to receive submissions of your work for our special edition. Our intention is to accommodate information about all aspects of the medicines optimisation process.
Prof John Marriott
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- evidence-based medicines
- medicines supply
- medicines administration
- medicines adherence
- cost-effective medicines use
- medicines waste
- medicines safety
- care pathways